<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: The aim of this study was to use lipidomics to determine if the <z:chebi fb="23" ids="18059">lipid</z:chebi> composition of <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi>-B-containing <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> is modified by <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and if any of the identified changes potentially have biological relevance in the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:chebi fb="1" ids="39027">VLDL</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> from normolipidaemic and dyslipidaemic type 2 diabetic women and controls were isolated and quantified with HPLC and mass spectrometry </plain></SENT>
<SENT sid="2" pm="."><plain>A detailed molecular characterisation of <z:chebi fb="0" ids="47776">VLDL triacylglycerols</z:chebi> (TAG) was also performed using the novel ozone-induced dissociation method, which allowed us to distinguish <z:chebi fb="0" ids="36023">vaccenic acid</z:chebi> (C18:1 n-7) from <z:chebi fb="0" ids="16196">oleic acid</z:chebi> (C18:1 n-9) in specific TAG species </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:chebi fb="23" ids="18059">Lipid</z:chebi> class composition was very similar in <z:chebi fb="1" ids="39027">VLDL</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> from normolipidaemic type 2 diabetic and control participants </plain></SENT>
<SENT sid="4" pm="."><plain>By contrast, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> was associated with significant changes in both <z:chebi fb="23" ids="18059">lipid</z:chebi> classes (e.g. increased <z:chebi fb="0" ids="18035">diacylglycerols</z:chebi>) and <z:chebi fb="23" ids="18059">lipid</z:chebi> species (e.g. increased C16:1 and C20:3 in <z:chebi fb="0" ids="49183">phosphatidylcholine</z:chebi> and cholesteryl <z:chebi fb="21" ids="35701">ester</z:chebi> and increased C16:0 [<z:chebi fb="0" ids="15756">palmitic acid</z:chebi>] and <z:chebi fb="0" ids="36023">vaccenic acid</z:chebi> in TAG) </plain></SENT>
<SENT sid="5" pm="."><plain>Levels of <z:chebi fb="0" ids="15756">palmitic acid</z:chebi> in <z:chebi fb="1" ids="39027">VLDL</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> TAG correlated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, and <z:chebi fb="1" ids="39027">VLDL</z:chebi> TAG enriched in <z:chebi fb="0" ids="15756">palmitic acid</z:chebi> promoted increased secretion of proinflammatory mediators from human smooth muscle cells </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: We showed that <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidaemia</z:e> is associated with major changes in both <z:chebi fb="23" ids="18059">lipid</z:chebi> class and <z:chebi fb="23" ids="18059">lipid</z:chebi> species composition in <z:chebi fb="1" ids="39027">VLDL</z:chebi> and <z:chebi fb="15" ids="39026">LDL</z:chebi> from women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, we identified specific molecular <z:chebi fb="23" ids="18059">lipid</z:chebi> species that both correlate with clinical variables and are proinflammatory </plain></SENT>
<SENT sid="8" pm="."><plain>Our study thus shows the potential of advanced lipidomic methods to further understand the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>